Susceptibility of canine and feline bacterial pathogens to pradofloxacin and comparison with other fluoroquinolones approved for companion animals

Veterinary Microbiology

Volumn 162, Issue 1, 2013, Pages 119-126

  Schink, Anne Kathrin ^a   Kadlec, Kristina ^a   Hauschild, Tomasz ^a,d   Brenner Michael, Geovana ^a   Dörner, Julia C ^b   Ludwig, Carolin ^b   Werckenthin, Christiane ^c   Hehnen, Hans Robert ^b   Stephan, Bernd ^b   Schwarz, Stefan ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b BAYER PHARMA AG   (Germany)

^c Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit LAVES   (Germany)

^d UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Cats; Dogs; Minimum inhibitory concentration; Target gene mutation

Indexed keywords

DIFLOXACIN; DRUG METABOLITE; ENROFLOXACIN; GYRASE INHIBITOR; IBAFLOXACIN; MARBOFLOXACIN; ORBIFLOXACIN; PRADOFLOXACIN; PROTEIN PARC;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BETA HEMOLYTIC STREPTOCOCCUS; BORDETELLA BRONCHISEPTICA; CAT; CONTROLLED STUDY; DOG; ESCHERICHIA COLI; GENE MUTATION; GENE TARGETING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PASTEURELLA MULTOCIDA; PROTEUS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PSEUDINTERMEDIUS;

ANIMALS; ANTI-BACTERIAL AGENTS; CAT DISEASES; CATS; DOG DISEASES; DOGS; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; PETS; STAPHYLOCOCCUS;

ANIMALIA; BACTERIA (MICROORGANISMS); BORDETELLA BRONCHISEPTICA; CANIS FAMILIARIS; ESCHERICHIA COLI; FELIDAE; PASTEURELLA MULTOCIDA; PROTEUS (ENTEROBACTERIA); PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PSEUDINTERMEDIUS;

EID: 84872179576     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2012.08.001     Document Type: Article

References (26)

1. Abraham J., Ewert K., de Jong A. Pradofloxacin: comparative in vitro activity against selected pathogens from the US. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 2002, p. 189. Abstract F-568.
2. Biswas S., Maggi R.G., Papich M.G., Keil D., Breitschwerdt E.B. Comparative activity of pradofloxacin, enrofloxacin, and azithromycin against Bartonella henselae isolates collected from cats and a human. J. Clin. Microbiol. 2010, 48:617-618.
3. Bywater R., Silley P., Simjee S. Antimicrobial breakpoints-definitions and conflicting requirements. Vet. Microbiol. 2006, 118:158-159.
4. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Disk and Dilution Susceptibility Test for Bacteria Isolated from Animals; Approved Standard 2008, Clinical and Laboratory Standards Institute, Wayne, PA, USA, CLSI document M31-A3. third ed.
5. Descloux S., Rossano A., Perreten V. Characterization of new staphylococcal cassette chromosome mec (SCCmec) and topoisomerase genes in fluoroquinolone- and methicillin-resistant Staphylococcus pseudintermedius. J. Clin. Microbiol. 2008, 46:1818-1823.
6. Gibson J.S., Cobbold R.N., Kyaw-Tanner M.T., Heisig P., Trott D.J. Fluoroquinolone resistance mechanisms in multidrug-resistant Escherichia coli isolated from extraintestinal infections in dogs. Vet. Microbiol. 2010, 146:161-166.
7. Govendir M., Norris J.M., Hansen T., Wigney D.I., Muscatello G., Trott D.J., Malik R. Susceptibility of rapidly growing mycobacteria and Nocardia isolates from cats and dogs to pradofloxacin. Vet. Microbiol. 2011, 153:240-245.
8. Greene C.E., Budsberg S.C. Veterinary use of quinolones. Quinolone Antimicrobial Agents 1993, 473-488. American Society for Microbiology Press, Washington, DC. 2nd ed. D.C. Hooper, J.S. Wolfson (Eds.).
9. Grobbel M., Lübke-Becker A., AleŠík E., Schwarz S., Wallmann J., Werckenthin C., Wieler L.H. Antimicrobial susceptibility of Escherichia coli from swine, horses, dogs and cats as determined in the BfT-GermVet monitoring program 2004-2006. Berl. Münch. Tierärztl. Wochenschr. 2007, 120:391-401.
10. Grobbel M., Lübke-Becker A., AleŠík E., Schwarz S., Wallmann J., Werckenthin C., Wieler L.H. Antimicrobial susceptibility of Klebsiella spp. and Proteus spp. from various organ systems of horses, dogs and cats as determined in the BfT-GermVet monitoring program 2004-2006. Berl. Münch. Tierärztl. Wochenschr. 2007, 120:402-411.
11. Hopkins K.L., Davies R.H., Threlfall E.J. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int. J. Antimicrob. Agents 2005, 25:358-373.
12. Intorre L., Vanni M., Di Bello D., Pretti C., Meucci V., Tognetti R., Soldani G., Cardini G., Jousson O. Antimicrobial susceptibility and mechanism of resistance to fluoroquinolones in Staphylococcus intermedius and Staphylococcus schleiferi. J. Vet. Pharmacol. Ther. 2007, 30:464-469.
13. CTX-M-carrying plasmids from Escherichia coli isolates collected in the BfT-GermVet study. Appl. Environ. Microbiol. 2011, 77:7142-7146.
14. Schink A.-K., Kadlec K., Schwarz S. Detection of qnr genes among Escherichia coli isolates of animal origin and complete sequence of the conjugative qnrB19-carrying plasmid pQNR2078. J. Antimicrob. Chemother. 2012, 67:1099-1102.
15. Schwarz S., AleŠík E., Grobbel M., Lübke-Becker A., Wallmann J., Werckenthin C., Wieler L.H. The BfT-GermVet monitoring program - aims and basics. Berl. Münch. Tierärztl. Wochenschr. 2007, 120:357-362.
16. Schwarz S., Alešík E., Werckenthin C., Grobbel M., Lübke-Becker A., Wieler L.H., Wallmann J. Antimicrobial susceptibility of coagulase-positive and coagulase-variable staphylococci from various indications of swine, dogs and cats as determined in the BfT-GermVet monitoring program 2004-2006. Berl. Münch. Tierärztl. Wochenschr. 2007, 120:372-379.
17. Schwarz S., Alešík E., Grobbel M., Lübke-Becker A., Werckenthin C., Wieler L.H., Wallmann J. Antimicrobial susceptibility of streptococci from various indications of swine, horses, dogs and cats as determined in the BfT-GermVet monitoring program 2004-2006. Berl. Münch. Tierärztl. Wochenschr. 2007, 120:380-390.
18. Schwarz S., Alešík E., Grobbel M., Lübke-Becker A., Werckenthin C., Wieler L.H., Wallmann J. Antimicrobial susceptibility of Pasteurella multocida and Bordetella bronchiseptica from dogs and cats as determined in the BfT-GermVet monitoring program 2004-2006. Berl. Münch. Tierärztl. Wochenschr. 2007, 120:423-430.
19. Schwarz S., Silley P., Simjee S., Woodford N., van Duijkeren E., Johnson A.P., Gaastra W. Assessing the antimicrobial susceptibility of bacteria obtained from animals. Vet. Microbiol. 2010, 141:1-4.
20. Silley P., Stephan B., Greife H.A., Pridmore A. Bactericidal properties of pradofloxacin against veterinary pathogens. Vet. Microbiol. 2012, 157:106-111.
21. Silley P., Stephan B., Greife H.A., Pridmore A. Comparative activity of pradofloxacin against anaerobic bacteria isolated from dogs and cats. J. Antimicrob. Chemother. 2007, 60:999-1003.
22. Simjee S., Silley P., Werling H.O., Bywater R. Potential confusion regarding the term 'resistance' in epidemiological surveys. J. Antimicrob. Chemother. 2008, 61:228-229.
23. Stephan B., Friederichs S., Pridmore A., Hellmann K., Adler K., Edingloh M., Greife H.A. Novel fluoroquinolone pradofloxacin: clinical efficacy and safety in the treatment of feline wound infections. J. Vet. Pharmacol. Therap. 2006, 29(Suppl. 1):77-78.
24. Stephan B., Greife H.A., Pridmore A., Silley P. Activity of pradofloxacin against Porphyromonas and Prevotella spp. implicated in periodontal disease in dogs: susceptibility test data from a European multicenter study. Antimicrob. Agents Chemother. 2008, 52:2149-2155.
25. Werckenthin C., Alešík E., Grobbel M., Lübke-Becker A., Schwarz S., Wieler L.H., Wallmann J. Antimicrobial susceptibility of Pseudomonas aeruginosa from dogs and cats as well as Arcanobacterium pyogenes from cattle and swine as determined in the BfT-GermVet monitoring program 2004-2006. Berl. Münch. Tierärztl. Wochenschr. 2007, 120:412-422.
26. Wetzstein H.G. Comparative mutant prevention concentrations of pradofloxacin and other veterinary fluoroquinolones indicate differing potentials in preventing selection of resistance. Antimicrob. Agents Chemother. 2005, 49:4166-4173.